Muscle Function in Osteogenesis Imperfecta Type IV

Calcif Tissue Int. 2017 Oct;101(4):362-370. doi: 10.1007/s00223-017-0287-y. Epub 2017 May 4.

Abstract

Results of previous studies suggest that children and adolescents with osteogenesis imperfecta (OI) type IV have muscle force deficits. However, muscle function remains to be objectively quantified in this population. This study aimed to assess upper and lower extremity muscle function in patients with OI type IV. It was carried out in the outpatient department of a pediatric orthopedic hospital; 27 individuals with OI type IV (7-21 years; 13 males), 27 age- and sex-matched individuals with OI type I, and 27 age- and sex-matched controls. Upper extremity muscle force was assessed with hydraulic hand dynamometry, and lower extremity muscle function (peak force per body weight and peak power per body mass) was measured by mechanography through five tests: multiple two-legged hopping, multiple one-legged hopping, single two-legged jump, chair-rise test, and heel-rise test. Upper-limb grip force was normal for patients with OI type IV when compared to height and sex reference data (average z-score = 0.17 ± 1.30; P = 0.88). Compared to age- and sex-matched controls, patients with OI type IV had approximately 30% lower-limb peak force and 50% peak power deficits (P values <0.05). At the lower-limb level, they had a 50% lower peak power than age- and sex-matched patients with OI type I (P < 0.05). Patients with OI type IV have normal upper-limb muscle force but a muscle function deficit at the lower-limb level. These results suggest that lower-limb muscle weakness may contribute to functional deficits in these individuals.

Keywords: Lower-limb muscle function; Maximum isometric grip force; Mechanography; Muscle power; Osteogenesis imperfect; Upper-limb muscle force.

MeSH terms

  • Adolescent
  • Child
  • Female
  • Humans
  • Male
  • Muscle Strength / physiology*
  • Muscle, Skeletal / physiopathology*
  • Osteogenesis Imperfecta / physiopathology*
  • Young Adult

Substances

  • Osteogenesis Imperfecta, Type IV